BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q2 2023 Earnings Call Transcript August 3, 2023 BioCryst Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.24 EPS, expectations were $0.25. Operator: Good morning and welcome to the BioCryst Second Quarter 2023 Earnings Call. [Operator Instructions] Please note this event is being recorded. I would now like to turn […]
StockWatch: Investors Shrug as FDA Weighs First Gene-Edited Therapy genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.